Orion Struggles To Make Headway With Rival To Seretide
Executive Summary
You may also be interested in...
Orion Defends Position In Declining Finnish Market
Amid declining sales of drugs covered by reference prices in Finland, local leader Orion says it has been able to slightly strengthen its market position.
Easyhaler Line Breathes Life Into Ailing Orion
Expanding sales from its Easyhaler line of respiratory devices alleviated pressure on Orion in the first quarter of 2019 as the Finnish group found most of its key product franchises under pressure.
Pressure Mounts For German Tender Reforms
Germany’s off-patent industry association, Pro Generika, is finding ample support for its position that by awarding tender contracts to exclusive suppliers, health insurance funds are contributing to drug shortages in the country.